21 Century Medicine, Inc.; Fontana, CA USA.
Organogenesis. 2009 Jul;5(3):167-75. doi: 10.4161/org.5.3.9974.
Cryopreservation would potentially very much facilitate the inventory control and distribution of laboratory-produced organs and tissues. Although simple freezing methods are effective for many simple tissues, bioartificial organs and complex tissue constructs may be unacceptably altered by ice formation and dissolution. Vitrification, in which the liquids in a living system are converted into the glassy state at low temperatures, provides a potential alternative to freezing that can in principle avoid ice formation altogether. The present report provides a brief overview of the problem of renal vitrification. We report here the detailed case history of a rabbit kidney that survived vitrification and subsequent transplantation, a case that demonstrates both the fundamental feasibility of complex system vitrification and the obstacles that must still be overcome, of which the chief one in the case of the kidney is adequate distribution of cryoprotectant to the renal medulla. Medullary equilibration can be monitored by monitoring urine concentrations of cryoprotectant, and urine flow rate correlates with vitrification solution viscosity and the speed of equilibration. By taking these factors into account and by using higher perfusion pressures as per the case of the kidney that survived vitrification, it is becoming possible to design protocols for equilibrating kidneys that protect against both devitrification and excessive cryoprotectant toxicity.
低温保存将极大地方便实验室生产的器官和组织的库存控制和分配。虽然简单的冷冻方法对许多简单组织有效,但生物人工器官和复杂组织构建体可能会因冰的形成和溶解而受到不可接受的改变。玻璃化,即将生物系统中的液体在低温下转化为玻璃态,为冷冻提供了一种潜在的替代方法,原则上可以完全避免冰的形成。本报告简要概述了肾脏玻璃化的问题。我们在这里报告了一个兔子肾脏玻璃化和随后移植的详细案例历史,该案例证明了复杂系统玻璃化的基本可行性以及仍然必须克服的障碍,其中肾脏的主要障碍是将冷冻保护剂充分分配到肾脏髓质。通过监测冷冻保护剂的尿液浓度,可以监测髓质平衡,尿液流速与玻璃化溶液粘度和平衡速度相关。通过考虑这些因素,并根据幸存的肾脏玻璃化情况使用更高的灌注压力,可以设计出针对防止玻璃化和过度冷冻保护剂毒性的肾脏平衡方案。